Skip to main content

and
  1. Article

    Open Access

    Target occupancy study and whole-body dosimetry with a MAGL PET ligand [11C]PF-06809247 in non-human primates

    Monoacylglycerol lipase (MAGL) is a key serine hydrolase which terminates endocannabinoid signaling and regulates arachidonic acid driven inflammatory responses within the central nervous system. To develop [11C]...

    Ryosuke Arakawa, Akihiro Takano, Sangram Nag, Zhisheng Jia, Nahid Amini in EJNMMI Research (2022)

  2. Article

    Open Access

    PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18F]PF-06684511

    Beta-secretase 1 (BACE1) enzyme is implicated in the pathophysiology of Alzheimer’s disease. [18F]PF-06684511 is a positron emission tomography (PET) radioligand for imaging BACE1. Despite favorable brain kinetic...

    Ryosuke Arakawa, Akihiro Takano in European Journal of Nuclear Medicine and M… (2020)

  3. Article

    Open Access

    Potential for imaging the high-affinity state of the 5-HT1B receptor: a comparison of three PET radioligands with differing intrinsic activity

    Over the last decade, a few radioligands have been developed for PET imaging of brain 5-HT1B receptors. The 5-HT1B receptor is a G-protein-coupled receptor (GPCR) that exists in two different agonist affinity sta...

    Anton Lindberg, Ryosuke Arakawa, Tsuyoshi Nogami, Sangram Nag in EJNMMI Research (2019)

  4. Article

    Open Access

    Test-retest reproducibility of [11C]-l-deprenyl-D2 binding to MAO-B in the human brain

    [11C]-l-deprenyl-D2 is a positron emission tomography (PET) radioligand for measurement of the monoamine oxidase B (MAO-B) activity in vivo brain. The estimation of the test-retest reproducibility is important fo...

    Ryosuke Arakawa, Per Stenkrona, Akihiro Takano, Sangram Nag in EJNMMI Research (2017)

  5. No Access

    Article

    Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects

    Imaging of the 18-kDa translocator protein (TSPO) is a potential tool for examining microglial activation and neuroinflammation in early Alzheimer’s disease (AD). [18F]FEMPA is a novel high-affinity second-genera...

    Andrea Varrone, Vesa Oikonen, Anton Forsberg in European Journal of Nuclear Medicine and M… (2015)

  6. No Access

    Article

    In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients

    Imaging the 18-kDa translocator protein (TSPO) is considered a potential tool for in vivo evaluation of microglial activation and neuroinflammation in the early stages of Alzheimer’s disease (AD). ((R)-1-(2-chlor...

    Andrea Varrone, Patrik Mattsson in European Journal of Nuclear Medicine and M… (2013)

  7. Article

    Open Access

    In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106

    The activation of microglia, in general, and the upregulation of the translocator protein (18 kDa) (TSPO) system, in particular, are key features of neuroinflammation, of which the in vivo visualization and quant...

    Akihiro Takano, Fredrik Piehl, Jan Hillert, Andrea Varrone, Sangram Nag in EJNMMI Research (2013)